Nucletron Corporation, an Elekta AB (SE:EKTAB) Company, Introduces Esteya, Electronic Brachytherapy for Treating Skin Cancer
9/23/2013 9:56:13 AM
ATLANTA--(BUSINESS WIRE)--Regulatory News: Nucletron, an Elekta company, and the world leader in brachytherapy, has launched Esteya®, a new approach for treating patients with skin cancer.
Help employers find you! Check out all the jobs and post your resume.
comments powered by